Ms. Nancy Stuart has been the Chief Operating Officer of Concert Pharmaceuticals, Inc. since October 2007. Ms. Stuart served as Principal Financial Officer of Concert Pharmaceuticals, Inc. until January 23, 2014 and also its Senior Vice President of Corporate Strategy & Operations from July 2006 to October 2007. Prior to joining Concert in July 2006, Ms. Stuart held various business operations and business development positions at Amgen Inc., a biopharmaceutical company, Kinetix Pharmaceuticals, Inc., a pharmaceutical company subsequently acquired by Amgen, Scion Pharmaceuticals, Inc., a pharmaceutical company, Vertex, a pharmaceutical company and Genzyme Corporation, a biotechnology company subsequently acquired by Sanofi S.A. She also held senior level business and drug development positions at RRD International. At Vertex, she was the Vice President of the Program Planning and Management Department and was responsible for Vertex's strategic partnerships and global drug development programs. She co-directed the development of Agenerase??? at Vertex and initiated the Thyrogen??? program at Genzyme. Ms. Stuart has over 20 years of biotechnology and pharmaceutical industry experience. Ms. Stuart holds a B.S. from the University of Michigan and an M.B.A. from the Simmons College Graduate School of Management.